Silo Pharma Inc. highlights U.S. federal actions advancing the development of psychedelic-based therapies for mental health and substance use disorders, anticipating innovation in PTSD and addiction treatment.
Silo Pharma Inc. highlights U.S. federal actions advancing the development of psychedelic-based therapies for mental health and substance use disorders, anticipating innovation in PTSD and addiction treatment.